GlassScriptPhysician profile
Kyle M Ryberg
NPI 1891144648
$888.48
in general payments reported to CMS, 2019-2025
21 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $354 · 2020: $301 · 2021: $40.41 · 2022: $141 · 2023: $51.87.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $51.87.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $51.87 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astellas Pharma US INC | $102.34 | 2019-2022 | |
| Abbvie INC. | $100.04 | 2020-2023 | Vraylar |
| Astrazeneca Pharmaceuticals LP | $83.78 | 2019-2020 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $80.52 | 2019-2020 | |
| Glaxosmithkline, LLC. | $70.78 | 2019-2021 | |
| Novo Nordisk INC | $61.43 | 2019-2022 | |
| Takeda Pharmaceuticals U.S.A., INC. | $55.88 | 2019-2020 | |
| Amarin Pharma, INC. | $49.86 | 2019 | |
| Allergan, INC. | $41.94 | 2019-2020 | |
| Dexcom, INC. | $38.40 | 2022 | |
| Pfizer INC. | $36.62 | 2020-2022 | |
| Lilly USA, LLC | $34.65 | 2019-2020 | |
| Abbott Laboratories | $33.29 | 2022-2023 | Proclaim |
| Boehringer Ingelheim Pharmaceuticals, INC. | $14.02 | 2019 | |
| Adlon Therapeutics L.P. | $13.90 | 2020 |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Biosense Webster, INC. | $13.03 | 2019 | |
| Sanofi-Aventis U.S. LLC | $11.84 | 2020 | |
| Arbor Pharmaceuticals, INC. | $11.79 | 2020 | |
| Genentech USA, INC. | $11.62 | 2019 | |
| Merck Sharp & Dohme LLC | $11.59 | 2020 | |
| Amgen INC. | $11.16 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Kyle Ryberg listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.